Literature DB >> 8566955

Identification of four novel splice site mutations in the ornithine transcarbamylase gene.

E Oppliger Leibundgut1, B Wermuth, J P Colombo, S Liechti-Gallati.   

Abstract

Ornithine transcarbamylase (OTC) deficiency, the most common inborn error of the urea cycle, shows X-linked inheritance with frequent new mutations. Using polymerase chain reaction (PCR) amplification of the individual exons including adjacent intron sequences followed by direct sequencing of the amplimers we identified four new mutations affecting donor splice sites of introns 2, 5, 6, and 8. The mutation at the first position of intron 2 was a G to A exchange associated with acute neonatal hyperammonemia in a male patient at the age of 5 months. A G to C substitution in intron 5 was detected in a boy who developed 2 days after birth hypotonia, and respiratory distress, followed by severe hyperammonemia and terminal coma. The intron 6 mutation, a G to T substitution, was detected in a girl presenting with first episodes of vomiting and agitation at the age of 2 months. The mutation in intron 8, also a G to T transition, caused fatal hyperammonemia and early death at the age of 15 days in a male patient. We present four donor splice site mutations resulting in severe neonatal or very early onset of the disease in three boys and in one female patient. As the GT dinucleotide of the 5' donor splice site is invariant and required for correct splicing the described mutations may lead to improperly spliced mRNAs and aberrant gene products.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566955     DOI: 10.1007/bf02265267

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  38 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency.

Authors:  R P Carstens; W A Fenton; L R Rosenberg
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

3.  Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.

Authors:  D Hentzen; A Pelet; D Feldman; D Rabier; J Berthelot; A Munnich
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

4.  Mosaicism for an intragenic deletion in a boy with mild ornithine transcarbamylase deficiency.

Authors:  A Maddalena; D M Sosnoski; G T Berry; R L Nussbaum
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

5.  Isolation of genomic DNA.

Authors:  B G Herrmann; A M Frischauf
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Scanning detection of mutations in human ornithine transcarbamoylase by chemical mismatch cleavage.

Authors:  M Grompe; D M Muzny; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Screening for gene deletions and known mutations in 13 patients with ornithine transcarbamylase deficiency.

Authors:  P J Suess; M Y Tsai; R A Holzknecht; M Horowitz; M Tuchman
Journal:  Biochem Med Metab Biol       Date:  1992-06

8.  Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency.

Authors:  M Tuchman; I Matsuda; A Munnich; S Malcolm; S Strautnieks; T Briede
Journal:  Am J Med Genet       Date:  1995-01-02

9.  Isolation and characterization of the human ornithine transcarbamylase gene: structure of the 5'-end region.

Authors:  A Hata; T Tsuzuki; K Shimada; M Takiguchi; M Mori; I Matsuda
Journal:  J Biochem       Date:  1986-09       Impact factor: 3.387

10.  DNA analysis for ornithine transcarbamylase deficiency.

Authors:  R Rozen; J E Fox; A M Hack; W A Fenton; A L Horwich; L E Rosenberg
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

View more
  1 in total

1.  Alternative Start Sites Downstream of Non-Sense Mutations Drive Antigen Presentation and Tolerance Induction to C-Terminal Epitopes.

Authors:  Scott N Ashley; Suryanarayan Somanathan; Christian Hinderer; Maxwell Arias; Deirdre McMenamin; Christine Draper; James M Wilson
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.